AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
McKesson's Trading Volume Drops 39.56% to $296 Million Ranking 280th in Market
Generated by AI AgentAinvest Volume Radar
Tuesday, Jun 24, 2025 8:01 pm ET1min read
On June 24, 2025, McKesson's trading volume was $296 million, a 39.56% decrease from the previous day, ranking 280th in the day's stock market.
Corp (MCK) fell 0.07%.McKesson Corp is one of the three leading pharmaceutical wholesalers in the US, specializing in sourcing and distributing branded, generic, and specialty pharmaceutical products to various pharmacies, hospital networks, and healthcare providers. Along with Cencora and Cardinal Health, these three companies dominate over 90% of the US pharmaceutical wholesale industry. Beyond the US, McKesson is also involved in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions for pharmacies.
McKesson Corporation has recently acquired a 70% controlling stake in Community Oncology Revitalization Enterprise Ventures, LLC - Core Ventures. This strategic move is expected to enhance McKesson's position in the oncology market, potentially driving future growth and innovation in cancer care services.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet